J F Holland

Medicine · Health Sciences

22h-index1.7kcitations69works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(13), Acute Myeloid Leukemia Research(10), Lymphoma Diagnosis and Treatment(7), Chronic Lymphocytic Leukemia Research(6), Chronic Myeloid Leukemia Treatments(6)

Publications69 total

Clinical Trials of the Acute Leukemia Group B in Acute Lymphocytic Leukemia of Childhood
Proceedings of the International Symposium on Comparative Leukemia Research·2015· 8 cited
Chemoimmunotherapy in Human and Experimental Leukemia1
Proceedings of the International Symposium on Comparative Leukemia Research·2015
P-274 Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents
Leukemia Research·2013
Prevention of Doxorubicin Cardiopathic Changes by a Benzyl Styryl Sulfone in Mice
Genes & Cancer·2011· 23 citedOpen Access
Final results of a phase I dose-escalation study of ON 01910.Na in combination with oxaliplatin in patients with advanced solid tumors.
Journal of Clinical Oncology·2011· 5 cited
Transfusion independence in patients with myelodysplastic syndromes treated with azacitidine
Journal of Clinical Oncology·2006· 1 cited
Identification of a retrovirus in human breast cancer
Journal of Clinical Oncology·2005
Effect of acid on duodenal blood flow and mucus secretion measured by reflectance spectrophotometry: a prospective, randomized‐controlled study
Alimentary Pharmacology & Therapeutics·2004· 4 citedOpen Access
Interleukin-2 plus chemotherapy for patients with metastatic melanoma
Melanoma Research·2000· 4 cited
Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas.
PubMed·1998· 17 cited
PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells
International Journal of Cancer·1998· 22 cited
Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
PubMed·1997· 10 cited
Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro.
PubMed·1997· 8 cited
77 Biological consequences of stromal abnormalities in the myelodysplastic syndrome (MDS): Its influence on the hematopoietic dysregulation
Leukemia Research·1997· 5 cited
Psychological Symptoms and Disease-Free and Overall Survival in Women With Stage II Breast Cancer
JNCI Journal of the National Cancer Institute·1996· 93 citedOpen Access
Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
PubMed·1996· 15 cited
Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
Molecular Pharmacology·1994· 50 cited
Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
PubMed·1994· 110 cited
Cancer Treatment An Update
1994· 16 cited
The first Claude Jacquillat Memorial Lecture : Chemotherapy of cancer
1991
page 1 of 4Next →

Frequent Co-authors

T Ohnuma(7), J. George Bekesi(5), Oliver Glidewell(4), Sandra J. Ginsberg(3), Larry Norton(3), N I Nissen(3), C. D. Bloomfield(3), Paolo Alberto Paciucci(3), Morton Coleman(3), Svetlana N. Zinzar(3), Z Arlin(3), Joseph Aisner(2), Michael Perloff(2), A. E. Korzun(2), Thambi Dorai(2), Gary K. Schwartz(2), Takao Ohnuma(2), Peter C. Raich(2), Thomas F. Pajak(2), Oleg S. Selawry(2)